Stockscreener 앱 받기
2.275
1.33%
0.025
전일 마감가:
$2.25
열려 있는:
$2.19
하루 거래량:
516.95K
Relative Volume:
0.17
시가총액:
$773.51M
수익:
-
순이익/손실:
$-75.80M
주가수익비율:
-6.50
EPS:
-0.35
순현금흐름:
$-68.07M
1주 성능:
+0.88%
1개월 성능:
+9.62%
6개월 성능:
-18.57%
1년 성능:
-25.97%
1일 변동 폭
$2.165
$2.28
1주일 범위
$2.00
$2.39
52주 변동 폭
$1.54
$3.97
Nuvation Bio Inc Stock (NUVB) Company Profile
명칭
Nuvation Bio Inc
전화
(415) 754-3517
주소
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
NUVB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
2.28 | 762.19M | 0 | -75.80M | -68.07M | -0.35 |
|
ONC
Beigene Ltd Adr
|
241.70 | 24.41B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.09 | 111.55B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.33 | 42.47M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
587.00 | 63.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
73.33 | 5.92B | 0 | -153.72M | -103.81M | -2.00 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-23 | 개시 | Citizens JMP | Mkt Outperform |
| 2024-03-27 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-03-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-01-06 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-08-02 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-05-04 | 개시 | H.C. Wainwright | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-04-06 | 개시 | RBC Capital Mkts | Outperform |
| 2021-03-08 | 개시 | BMO Capital Markets | Outperform |
| 2021-03-08 | 개시 | BTIG Research | Buy |
| 2021-03-08 | 개시 | Cowen | Outperform |
| 2021-03-08 | 개시 | Jefferies | Buy |
| 2021-03-08 | 개시 | Wedbush | Outperform |
모두보기
Nuvation Bio Inc 주식(NUVB)의 최신 뉴스
Nuvation Bio’s SWOT analysis: taletrectinib approval could transform stock outlook - Investing.com Australia
Nuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual Meeting - BioSpace
Northern Trust Corp Acquires 563,627 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Brokerages Set Nuvation Bio Inc. (NYSE:NUVB) Target Price at $7.83 - Defense World
Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way? - simplywall.st
Wedbush Reiterates Outperform Rating for Nuvation Bio (NYSE:NUVB) - Defense World
Nuvation Bio (NUVB) Maintains Outperform Rating by Wedbush | NUV - GuruFocus
Nuvation Bio (NUVB) Maintains Outperform Rating by Wedbush | NUVB Stock News - GuruFocus
Dimensional Fund Advisors LP Cuts Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Entrectinib at ISPOR 2025 - BioSpace
Breakthrough Comparison: How Nuvation's Cancer Drug Stacks Up Against Entrectinib in Crucial Lung Cancer Study - Stock Titan
Nuvation Bio Inc. (NYSE:NUVB) Q1 2025 Earnings Call Transcript - Insider Monkey
Nuvation Bio Inc. (NYSE:NUVB) Shares Bought by Price T Rowe Associates Inc. MD - Defense World
Nuvation Bio to Participate in Upcoming May 2025 Investor Conferences - BioSpace
Nuvation Bio’s Positive Outlook: Taletrectinib Approval and Financial Strength - TipRanks
Nuvation Bio to Participate in Upcoming Investor Conferences - Yahoo
Wedbush Issues Positive Outlook for Nuvation Bio Earnings - Defense World
FY2029 Earnings Forecast for Nuvation Bio Issued By Wedbush - Defense World
Nuvation Bio Inc (NUVB) Q1 2025 Earnings Call Highlights: Promising Developments and Strategic Moves - Investing.com Canada
Nuvation Bio Inc. (NUVB): Among Billionaire David Abrams’ Stock Picks with Huge Upside Potential - Insider Monkey
Nuvation Bio Inc. (NUVB) Reports Q1 Loss, Tops Revenue Estimates - MSN
Nuvation Bio: Undervalued Growth Potential with Key Developments on the Horizon - TipRanks
MetLife Investment Management LLC Buys 12,596 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Earnings call transcript: Nuvation Bio Q1 2025 sees strategic focus amid EPS miss - Investing.com
Nuvation Bio Reports First Quarter 2025 Financial Results and Provides Business Update - BioSpace
Nuvation Bio Reports Q1 2025 Results and Business Updates - TipRanks
Nuvation Bio (NUVB) Eyes U.S. Approval for Key Lung Cancer Treat - GuruFocus
Nuvation Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Stock Performance Spotlight: Nuvation Bio Inc (NUVB) Ends the Day at 2.09, Down by -12.18 - DWinneX
Nuvation Bio: A Real Shot To Move The Needle In Lung Cancer Subtypes (NYSE:NUVB) - Seeking Alpha
Wells Fargo & Company MN Increases Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio (NYSE:NUVB) Shares Down 8.2% After Insider Selling - Defense World
Nuvation Bio Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
JPMorgan Chase & Co. Sells 322,798 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc (NUVB) Stock: A Year of Stock Market Dynamics - investchronicle.com
Invesco Ltd. Buys 7,344 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
LPL Financial LLC Grows Holdings in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio to Present at The Citizens Life Sciences Conference - BioSpace
Nuvation Bio Inc [NUVB] Records 50-Day SMA of $1.98 - knoxdaily.com
Nuvation Bio Inc (NUVB) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Nuvation Bio Inc (NUVB)’s stock price range in the last year - uspostnews.com
Renaissance Technologies LLC Has $1.51 Million Stake in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Legal & General Group Plc Buys 62,877 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio Inc [NUVB] Investment Guide: What You Need to Know - knoxdaily.com
An Overview of Nuvation Bio Inc (NYSE: NUVB)’s Stock Performance and Outlook - Marketing Sentinel
Russell Investments Group Ltd. Buys 15,791 Shares of Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Cerity Partners LLC Makes New Investment in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Nuvation Bio (NYSE:NUVB) Earns Market Outperform Rating from Analysts at JMP Securities - Defense World
Nuvation Bio (NYSE:NUVB) Earns Mkt Outperform Rating from Analysts at Citizens Jmp - Defense World
Analysts Set Nuvation Bio Inc. (NYSE:NUVB) PT at $7.83 - Defense World
Nuvation Bio Inc [NUVB] Records 200-Day SMA of $2.57 - knoxdaily.com
Nuvation Bio Inc (NUVB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
13.67%
자본화:
|
볼륨(24시간):